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L.L. Nwidu et al. 345days. Thereafter, acute hepatotoxicity was evaluated in
36 Wistar rats divided into six groups (AeF) of six ani-
mals each. Group A served as the negative control; B
received CCl4 1 mL/kg only; CeE received 70.7, 141.4,
and 282.8 mg/kg MCHL extract, respectively; and F
received silymarin 100 mg/kg daily for 7 days by oral
gavage. After 48 h, the rats were sacrificed, and samples
obtained from them were assayed for histological and
biochemical biomarkers of hepatotoxicity.
Results: The MCHL extracts significantly (p < 0.001
e0.05) reduced the increase in aspartate aminotransferase
(AST), alanine aminotransferase (ALT), alkaline phos-
phatase (ALP), conjugated bilirubin (CBIL), and total
bilirubin (TBIL) levels induced by CCl4 intoxication.
There was no significant alteration in haematological
indices or weight following administration of the MCHL
extracts. Histopathological examinations revealed mitotic
bodies in the 141.4 mg/kg MCHL extract-treated rats, an
indication of tissue repair processes.
Conclusion: The MCHL extract has a dose-specific hep-
atoprotective effect; hence, the utilisation of this extract
for the management of hepatitis requires caution.
Keywords: Hepatotoxicity; Hepatoprotection; Histopathology;
Musanga cecropioides leaf; Oxidative stress
 2018 The Authors.
Production and hosting by Elsevier Ltd on behalf of Taibah
University. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-
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Musanga cecropioides (Cecropiaceae) is commonly called
African cork wood tree or umbrella tree. The local names are
Aga agbawo (Yoruba), Ulu (Igbo), and Odzuma (Ghana). It
is an erect, rapidly growing tree of the deciduous tropical
West African rainforest. It is abundant in swampy forests,
riverside, or lakeside at altitudes of 700e1200 m. The tree
grows up to 20 m in height with an umbrella-shaped crown,
straight and cylindrical trunk (up to 2 m in girth), and stilt
adventitious roots of up to 3 m above ground level. The
botany of M. cecropioides has already been reported.1e4
In the traditional medicine of the Ibibio of the Southe
South region of Nigeria, infusion of the M. cecropioides leaf
and stem bark is used for the treatment of fever, jaundice,
acute gastric poisoning, and liver diseases. A M. cecropioides
decoction is used in the management of menstruation pain,
induction of labour, and lowering of elevated blood pressure
and high blood sugar levels, and as a dehydrant, expectorant,
anthelminthic, anti-dysenteric, and analgesic; it is also
commonly used in ethnomedicine to treat asthenia in infants
and restore appetite.3 The sap is drunk as a blood-purifier; for
cleansing the stomach; for management of blennorrhoea,
cough, and chest infections; as a galactagogue; and commonly
as a wash for persons with sleeping sickness, leprosy, and fever
to relieve aches and pains and rheumatism.3,5Pharmacological studies have established the uterotonic,6
oral hypotensive,3,7 hypoglycaemic, and antidiabetic effects8
of M. cecropioides. The compounds isolated from
M. cecropioides include kalaic acid, triterpenoid acids,6 and
bioactive compounds such as alkaloids, flavonoids, tannins,
free and bound anthraquinone, saponin, and cardiac
glycosides; anthocyanosides and cyanogenic glycosides were
reported to be absent.9 M. cecropioides leaf extract contains
isovitexin, vitexin, chlorogenic acid, catechin, and
procyanidins.10
Despite its enormous and profound uses, no scientific
evidence is available to justify the use ofM. cecropioides leaf
extract in Ibibio traditional medicines. This study was
therefore designed to validate the claim of hepatoprotective
efficacy of M. cecropioides hydromethanolic leaf (MCHL)
extract in the treatment of liver diseases and to elucidate the
possible mechanism(s) of actions. In this investigation, an
experimental rat model of carbon tetrachloride (CCl4)-
induced acute liver injury was utilised, as it is known to
generate lipid radicals that initiate the chain reactions of lipid
peroxidation within and outside hepatic cells, causing liver
damage.
Materials and Methods
General reagents and chemicals
CCl4, silymarin, diethyl ether, and methanol were pur-
chased from SigmaeAldrich, St. Louis, Missouri, USA.
Diagnostic kits for serum alanine aminotransferase (ALT),
aspartate aminotransferase (AST), alkaline phosphatase
(ALP), conjugated bilirubin (CBIL), and total bilirubin
(TBIL) were purchased from Randox Laboratories Ltd.
London, UK. Other chemicals and solvents were of the
highest (analytical) grade commercially available and ob-
tained from either SigmaeAldrich or Merck, UK.
Plant collection and extraction
Fresh leaves of M. cecropioides were collected from Itak
Ikpa Local Government area of Akwa Ibom State, Nigeria.
The plants were collected by Mr. Etefia Okonand and iden-
tified by Mrs. Margaret Bassey of the Botany Department of
University of Uyo, Uyo, Nigeria. The leaf was collected in
January 2015 from the wild and the extract was stored for
two months before use. A voucher specimen (UUH 2001) of
the leaf was deposited at the herbarium of the Department of
Pharmacognosy, University of Uyo, Uyo, Nigeria.
Preparation of M. cecropioides leaf extract
Fresh leaves of M. cecropioides were air-dried and
powdered. The dry powder (300 g) was subjected to cold
extraction via maceration in 50% methanol (solvent). The
dry powder was soaked for a period of 72 h. The resultant
mixture was shaken twice daily for proper extraction.
Methanol was separated from the marc by filtration through
a double-layer gauge. The filtrate was evaporated to dryness
in vacuo at 55 C. The yield obtained was 4.5%. The extract
was stored in a refrigerator for up to four weeks for use in
assays.
Hepatoprotective effect of hydromethanolic leaf extract of Musanga cecropioides346Phytochemical screening
The extract was qualitatively screened for the presence of
alkaloids, saponins, anthraquinones, tannins, flavonoids,
and cardiac glycosides by using standard methods described
in the literature.11
Experimental animals
Thirty-six healthy adult Wistar rats of either sex and with
an average weight of 230e250 g were purchased from the
animal house of the Department of Pharmacology, Niger
Delta University, Bayelsa State. The animals were acclima-
tised for one week prior to the experiment. They were
maintained under standard laboratory conditions (a 12:12-
h dark/light period, 23  2 C temperature, and 55  5%
humidity). The animals were fed with a standard diet
(normal commercial pellet diet) and with water ad libitum.
All animal experiments conformed with the National Insti-
tute of Health Guide for Care and Use of Laboratory Ani-
mal (Pub No. 85-23, revised 1985) and were approved by the
Niger Delta University Ethical Committee on the use of
laboratory animals on February 20, 2015, via a circular
(NDU/2014/007).
In vivo pharmacological study
Acute toxicity studies
The median lethal dose (LD50) was determined by the
method described by Lorke12 with modification from the
report of Pereek et al.13 The Wistar albino rats used in this
study were starved for 24 h with free access to water except
for 2 h prior to experimentation. Varying doses (1000,
2000, 3000, and 5000 mg/kg i.p.) of the MCHL extract
were administered to four groups of rats (n ¼ 3) to
establish the range of doses of the extract that would elicit
toxic effects. The mice were observed for 24 h after
treatment for signs of excitement, sluggishness,
nervousness, alertness, convulsions, ataxia, or even death.
The LD50 was estimated by determining geometric means
of the dose that caused 100% mortality and the dose that
did not cause lethality.
Experimental design
Wistar albino rats of both sexes were randomised into six
groups, each comprising six rats (three males and three fe-
males). The protocol used for the study was as follows:
Group A was termed the negative control and received
distilled water (0.2 mL/kg, p.o.) once daily for six days.
Group B received distilled water (0.2 mL/kg bw by oral
dosing). Groups CeE received 70.7, 141.4, and 282.8 mg/kg
p.o. MCHL extract, respectively, once daily for seven days.
Group F was treated with silymarin 100 mg/kg once daily by
gavage for seven days. On the seventh day, groups B to F
were treated with a mixture of freshly prepared CCl4 in liquid
paraffin (1 mL/kg bw, 1:1 intraperitoneally), the dose effec-
tive in a pilot study, 1 h after administration of the last
treatment dose was administered. The body weights of all
rats were recorded daily throughout the seven days oftreatment. Blood was obtained by cardiac puncture and
collected into an EDTA vacutainer for determination of
haematological parameters by using an automated SYS-
MEX e KX21 Hematological Analyzer (SYSMEX Corpo-
ration, Japan). The haemoglobin (Hb) concentration,
packed cell volume (PCV), red blood cell (RBC) count, mean
corpuscular haemoglobin (MCH), mean corpuscular hae-
moglobin concentration (MCHC), mean corpuscular volume
(MCV), white blood cell (WBC) count, and platelet count
(PLC) were thus determined. For a biochemical assessment,
blood was spun at 3000 rpm for 10 min at 4 C to separate
serum; serum was stored in vacutainer vials at 4 C until
analysis. Livers were immediately extracted and perfused
with ice-cooled normal saline (0.9% sodium chloride) before
utilisation in further analyses.
Estimation of biochemical parameters
The serum collected was used to determine ALT, AST,
ALP, albumin (ALB), CBIL, TBIL, and total protein (TP)
by using Randox diagnostic kits. These analyses were per-
formed at the Department of Chemical Pathology, Niger
Delta Teaching Hospital (NDUTH), Okolobiri, Bayelsa
State, Nigeria.
The hepatoprotective activity (%) was determined using
the following formula:
Hepatoprotective activity ð%Þ
¼ ½1 ððHALAWÞ=ðRNWÞÞ  100
where MC, C, and W are the measured variables in rats
treated with MCHL extract plus CCl4, CCl4, and distilled
water, respectively.
Measurement of hepatic antioxidants/markers of lipid
peroxidation
Liver tissues from the experimental animals were perfused
with ice-cold saline and transported from the laboratory of
Faculty of Pharmacy Pharmacology, Niger Delta University,
on dry ice to the School of Medicine, University of Not-
tingham, Royal Derby Hospital Centre, Derby, UK, and
stored at 80 C until used for the assay of hepatic antiox-
idant enzymes. Liver pieces (100 mg) were diced and
homogenised in 100 mL of 5 mM Tris/HCl buffer (pH 7.4),
1 mM EDTA and complete mini protease inhibitor cocktail
(Roche). The homogenates were centrifuged at 10,000 rpm
for 10 min at 4 C and the clear supernatant used for the
estimation of antioxidant parameters (glutathione [GSH],
superoxide dismutase [SOD], catalase [CAT], and thio-
barbituric reacting substances [TBARS]).
GSH levels
GSH levels were determined based on the method
described by Ellman,14 with slight modifications. A
homogenate (0.2 mL) was mixed with 25% TCA and
centrifuged at 3000 rpm for 10 min. The supernatant
(0.2 mL) was mixed with 10 mM 5,50-dithiobis-(2-
nitrobenzoic acid (DTNB) in the presence of phosphate
buffer (0.1 M, pH 7.4) and absorbance was read at 420 nm.
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A CAT assay was performed according to the method
described by Aebi15 with slight modifications. The assay relies
upon the ultraviolet absorption of hydrogen peroxide that can
be measured at 240 nm. The decomposition of hydrogen
peroxide in the presence of CAT on a quartz plate allows
quantitation of catalase activity. Assays were performed in
the presence of 50 mM phosphate buffer. Hydrogen
peroxide decomposition was monitored in a 96-well quartz
plate using a Spectramax (Thermo Fisher) microplate reader.
CAT activity was expressed as units/mg protein.
SOD activity measurements
Liver cytosolic SOD activity was measured according to
the method described by Kakkar et al.16 Cytosol (0.05 mL)
was mixed with sodium pyrophosphate buffer (0.052 M,
pH 8.3, 1.2 mL), phenazine methosulphate (0.186 mM,
0.1 mL), nitroblue tetrazolium chloride (0.3 mM, 0.3 mL),
and NADH (0.78 mM, 0.2 mL). The reaction was stopped
after 90 s by the addition of glacial acetic acid. The colour
intensity of the chromogen was extracted in butanol
solution (2.0 mL) with vigorous shaking. The mixture was
then centrifuged at 3000 rpm for 10 min, the supernatant
was extracted, and the absorbance at 560 nm was
determined using the Spectramax microplate reader.
Determination of TBARS
Lipid peroxidation was determined spectrophotometri-
cally by measuring the level of the lipid peroxidation prod-
uct, malondialdehyde (MDA), as described by Draper and
Hadley.17 MDA reacts with thiobarbituric acid (TBA) to
form a red/pink-coloured complex, which absorbs maxi-
mally in an acid solution at 532 nm. Spectrophotometric
measurements were recorded using the Spectramax micro-
plate reader.
Histopathological studies
A portion of the liver was cut into pieces of approximately
6 mm3 in size and fixed in 10% phosphate-buffered formal-
dehyde solution. These liver pieces were embedded in
paraffin wax before thin sections of 5 mm in thickness wereTable 1: Phytochemical constituents of Musanga cecropioides hydro
Phytochemicals Test
Alkaloids 2 mL of MCHL extract þ 2 mL of Dragendoff
Saponins 2 mL of extract shaken vigorously to observe the
Anthraquinone 2 mL of extract þ 10 mL of benzene, followed b
addition of 5 mL of 10% ammonia solution to th
Tannins 2 mL of MCHL extract þ FeCl3
Flavonoid 2 mL of MCHL extract þ 2 mL of 10% lead ac
Cardiac glycosides 2 mL of MCHL extract mixed with 2 mL of
chloroform þ CH2SO4
carefully added
(þ) to (þþ) ¼ detected in scant to moderate quantities.
MCHL: Musanga cecropioides hydromethanolic leaf.stained with haematoxylin-eosin (H&E). These thin liver
sections were made into permanent slides and examined
under a high-resolution microscope (Olympus BX60MF,
Japan), after which photomicrographs were taken at a
magnification of 400.
Statistical analysis
All statistical measures were performed using PRISM 5
(GraphPad Software Inc., San Diego, California USA).
Unless specified otherwise, results are expressed as the
mean  standard error of the mean (SEM) values. One-way
analysis of variance (ANOVA) was used to compare group
data, followed by Tukey’s multiple comparisons test. A p
value of <0.05 was considered significant.
Results
In vivo pharmacological assay
Haematological analysis
The effect of MCHL extract on haematological indices of
rats with CCl4-induced hepatotoxicity is shown in Table 1.
Treatment with the 70.7 mg/kg and 141.8 mg/kg doses of
the extract significantly (p < 0.05) increased the WBC
count and lymphocyte and neutrophil counts, respectively,
compared to the corresponding counts in the control
group. No significant effects were observed on the other
haematological parameters investigated.
Effect of MCHL extract on hepatic enzyme markers
The effects of administration of MCHL extracts on liver
biomarker enzymes are shown in Table 2. ALT, AST, and
ALP levels significantly (p < 0.001) increased by 49%,
64%, and 38% respectively. TP and ALB levels
significantly (p < 0.001) decreased by 30% and 132%
respectively in the 70.7 mg/kg MCHL extract-treated
group. CBIL and TBIL significantly increased by 187%
and 163%, respectively, following intoxication with CCl4
compared to the values in the negative control group
(p < 0.05 and p < 0.01, respectively). However, following
pretreatment with MCHL extracts at doses of 70.7, 141.4,
and 282.8 mg/kg and silymarin at 100 mg/kg, TP levels
significantly (p< 0.01e0.001) increased compared to those in
the CCl4 group; the percentage hepatoprotection observedmethanolic leaf extracts.
Observations Inference
reagent Dark orange precipitate þ
reaction Persistent froth unbroken upon standing þþ
y the
e filtrate
Presence of reddish colour 
Resultant solution turns woolly brown þ
etate Yellowish green precipitate þ
Deep reddish-brown colour at the
interface and a steroid ring
þ
Table 2: The effect of Musanga cecropioides hydromethanolic leaf extracts on CCl4-induced hepatotoxicity, as indicated by haema-
tological indices.
Parameter Group A Group B Group C Group D Group E Group F
PCV (%) 50  6.7 40  9.8 45  3.0 42  9.1 44  6.1 43  5.1
Hb (g/dl) 14  1.7 12  2.7 14  1.0 13  2.0 12  2.8 12  1.5
WBC (103 cells/mL) 13  4.0 6.7  2.3a 6.9  2.5a 12  4.1 12  1.5 11  2.3
PLT (103 cells/mL) 1002  290 323  361 325  301 458  226 734  673 273  178
RBC (106 cells/mL) 8.0  1.0 6.5  1.9 7.6  0.6 7.3  1.7 7.3  0.9 7.5  1.0
MCV (%) 62  2.5 59  3.6 59  3.4 58  2.6 60  5.9 57  3.1
MCH (pg) 18  0.9 17  1.5 17  1.4 18  2.6 16  3.0 16  2.3
MCHC (g/dl) 28  0.7 30  1.7 29  1.2 31  4.1 29  0.8 29  1.1
NEU (%) 38  8.2 51  8.0 44  12 56  11a 37  8.3 45  13
LYM (%) 63  8.7 42  7.1 48  13 39  13a 56  8.8 49  1.5
MEB (%) 4.7  1.6 6.6  1.1 7.5  2.9 5.8  2.8 7.0  2.9 6.7  2.5
Values represent mean  SEM, n¼ 6. Results are displayed relative to positive control values; ap< 0.05; statistical analysis was performed
using one-way ANOVA. Group A received 0.2 mL/kg distilled water; B received CCl4 1 mL/kg; C received 70.7 mg/kg MCHL
extractþ 1 mL CCl4; D received 140.4 mg/kgMCHL extractþ 1 mL CCl4; E received 282.8 mg/kgMCHL extractþ 1 mLCCl4; G received
100 mg/kg silymarin.
Abbreviations: PCV: packed cell volume, Hb: haemoglobin, WBC: white blood cells, PLT: platelets, RBC: red blood cells, MCV: mean
corpuscular volume, MCH: mean corpuscular haemoglobin, MCHC: mean corpuscular haemoglobin concentration, NEU: neutrophils,
LYM: lymphocytes; MEBs: monocytes, eosinophils, and basophils.
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ALT, AST, ALP, CBIL, and TBIL levels decreased signifi-
cantly (p < 0.05e0.001) following pretreatment with the
MCHL extract. In the group treated with the 70.7 mg/kg
MCHL extract, the percentage hepatoprotection for ALT,
AST, ALP, CBIL, and TBIL was 130%, 128%, 127%,
130%, and 124%, respectively. The corresponding values for
the group treated with the 141.4 mg/kg MCHL extract were
182%, 140%, 104%, 127%, and 116%. The group treated
with the highest dose of the MCHL extract (282.8 mg/kg)
showed no significant hepatoprotection for these enzyme
biomarkers. The percentage hepatoprotection afforded by
the pure drug silymarin at 100 mg/kg was 168%, 102%,
116%, 105%, 127%, 103%, and 100% for TP, ALT, AST,
ALP, ALB, CBIL, and TBIL, respectively.Phytochemical studies
A preliminary phytochemical screening of the MCHL
extract revealed the presence of alkaloids, saponins,Table 3: Effect of MCHL extract on biochemical parameters.
Treatment Dose TP ALT AST
Body weight (mg/kg) (g/dl) (IU/L) (IU/L
Control 0.0 17.7  0.7 52.3  2.4 41.7 
Positive 1 mL/kg CCl4 13.6  0.03*** 102.9  1.1*** 116.7
Control
MCHL extract CCl4 þ 70.7 17.8  0.7*** 67.3  0.3*** 62.6 
CCl4 þ 141.4 18.2  0.3*** 43.1  1.7*** 30.2 
CCl4 þ 282.8 16.2  0.2* 93.1  1.7 100.2
Silymarin CCl4 þ 100 16.4  0.3* 53.3  0.1*** 53.7 
Values represent means  SEM, n ¼ 6. Significant results of extracts a
positive control displayed relative to healthy (negative) control; results
For significance: *p < 0.05; **p < 0.01 and ***p < 0.001. Statistical ana
Abbreviations: MCHL extract, Musanga cecropioides hydromethanolic
aspartate aminotransferase; ALP: alkaline phosphatase; ALB: albuminanthraquinone, tannins, flavonoids, and cardiac glycosides.
The extract contained these bioactive agents in moderate
amounts as shown in Table 3.
Acute toxicity
The MCHL extract was found to be toxic at doses of
>2000 mg/kg. At 24 h, the numbers of dead/live animals
after treatment with 100, 200, 300, and 500 mg/kg were 0/3,
3/3, 3/3, and 3/3, respectively. The LD50 was found to be
1414.2 mg/kg. This justifies the use of MCHL extract doses
of 70.7, 141.8, and 282.8 mg/kg as the 1/20th, 1/10th, and 1/
5th LD50 dose used in this study.
Histopathological examination
The effects of 70.7, 141.8, and 282.8 mg/kg MCHL ex-
tracts and 100 mg/kg silymarin on the liver histology of
CCl4-intoxicated rats are shown in Figure 1. The section of
the control rat liver shows normal sinusoidal spaces with aALP ALB CBIL TBIL
) (IU/L) (g/dL) (mg/dL) (mg/dL)
3.8 56.7  1.2 8.6  0.3 10.9  0.2 16.7  0.9
 0.9*** 91.0  3.2*** 3.7  0.3*** 31.3  0.2*** 44.0  0.6***
0.8*** 66.0  1.2*** 8.3  0.7*** 17.0  1.1*** 22.0  0.9***
1.8*** 55.3  3.0*** 8.2  0.2*** 16.5  0.2*** 20.2  0.6***
 1.6 82.2  3.9 5.6  0.3 28.8  2.0 42.9  3.1
0.3*** 55.0  2.6*** 7.3  0.6*** 10.2  0.1*** 17.2  0.6***
nd pure drug are displayed relative to positive control values; and
with significant changes from controls are marked with asterisks.
lysis was performed using one-way ANOVA.
extract; TP: total protein; ALT: alanine aminotransferase; AST:
; CBIL: conjugated bilirubin; TBIL: total bilirubin.
Figure 1: Photomicrographs showing the effect of MCHL extract and silymarin on liver histopathology of CCl4-treated rats; stains: hae-
matoxylin & eosin; magnification, 3400. A. Vehicle-treated control liver tissue showing normal liver architecture with prominent hepa-
tocytes and numerous sinusoids. B. CCl4-treated control group section or liver biopsy showing ballooning degeneration, massive fatty
infiltration, and recruitment of inflammatory cells (predominantly neutrophils) within the portal tract and periportal zone, indicating
insult. C. Section from the group treated with the MCHL extract (70.7 mg/kg dose) and CCl4 showing an area of localized and complete
necrosis amidst viable hepatocytes. D. Section from the group treated with the MCHL extract (141.4 mg/kg dose) and CCl4 showing fibrin
deposition and numerous mitotic bodies, indicating healing. E. Section from the group treated with the MCHL extract (282.8 mg/kg dose)
and CCl4 showing moderate hepatic distension with multiple microvesicles, few lipoid cells, and inflammatory cells within the portal tract,
indicating injury. F. Section from the group treated with silymarin (100 mg/kg) and CCl4 showing an area of necrosis with numerous
mitotic bodies, indicating hepatocyte regeneration. MCHL: Musanga cecropioides hydromethanolic leaf; CCl4: carbon tetrachloride.
L.L. Nwidu et al. 349non-congested portal tract, differentiated blood vessels, and
viable hepatocytes (Figure 1A). Liver sections of rats
intoxicated with CCl4 indicate marked extensive necrosis,
steatosis, ballooning degeneration, gross mononuclear
infiltration, and loss of cellular boundaries of the
hepatocytes (Figure 1B). Pretreatment with the 70.7 mg/kg
MCHL extract showed minor amelioration of the
histopathological architecture truncated by CCL4
intoxication. Hepatocytes with an area of localized and
complete necrosis amidst viable hepatocytes were seen,
indicating that the hepatocyte insult (induced by CCl4) was
not yet fully resolved at this dose of MCHL extract
(Figure 1C). Following pretreatment with the 141.4 mg/kg
MCHL extract, areas of fibrin deposition and numerous
mitotic bodies were observed, indicating a healing process
and signs of hepatoprotection at this dose (Figure 1D).
Hepatocytes of the rats treated with 282.8 mg/kg MCHLextract showed multiple microvesicles, few lipoid cells, and
numerous inflammatory cells within the portal tract,
indicating injury and that this dose is not fully
hepatoprotective (Figure 1E). Following treatment with the
pure drug, silymarin, at 100 mg/kg, liver tissue with
numerous mitotic bodies was observed, demonstrating
hepatocyte regeneration and that silymarin is
hepatoprotective.
Effect of MCHL extracts on hepatic antioxidants and
markers of lipid peroxidation
To assess the effects of pretreatment with the MCHL
extract (70.7, 141.4, and 282.8 mg/kg) on oxidative stress
markers following acute CCL4 intoxication in rats, we
assayed liver homogenates for antioxidant capacity by
measuring CAT, GSH, SOD, and TBARS.
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Figure 3: The effect of CCl4, MCHL extract, and silymarin on
weight gain in rats through the course of the experiment. Data
presented above demonstrates that there were no significant effects
of the MCHL extract on the weights of the animals. MCHL:
Musanga cecropioides hydromethanolic leaf; CCl4: carbon
tetrachloride.
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(p < 0.001) reduced by 48%, 41%, and 31%, respectively,
after CCl4 intoxication compared to the corresponding levels
in the positive controls. However, only pretreatment with
MCHL (141.4 mg/kg) significantly (p< 0.01e0.05) increased
GSH, CAT, and SOD levels to 53%, 41%, and 21% while
silymarin (100 mg/kg) treatment significantly (p < 0.01e
0.001) increased GSH, CAT, and SOD levels by 75%, 50%,
and 22%, respectively, compared to the levels in the CCl4-
intoxicated group. The effects of other doses of the extract
were not significant (Figure 2).
Lipid peroxidation activity in the liver significantly
(p < 0.001) increased to 70% after CCl4 intoxication
compared to that in the negative control; however, pre-
treatment with the 141.1 mg/kg MCHL extract significantly
(p < 0.05) decreased the lipid peroxidation level by 18%. On
the other hand, pretreatment with silymarin significantly
(p < 0.001) reduced lipid peroxidation by 26% of that in the
positive controls. The lowest and highest doses of the extract
had no significant effect on lipid peroxidation levels.
Body weight evaluation
The effects of MCHL extracts on body weight gain in the
rats are shown in Figure 3. TheMCHL extracts led to a dose-
dependent and non-significant (p > 0.05) increase in body
weight gain compared to the initial depression in weight
following the CCl4 insult.
Discussion
Hepatotoxic insults commonly occur due to environ-
mental factors, industrial chemicals, drugs, and diseases such           GSH
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Figure 2: Effects of MCHL extract on markers of oxidative stress. Level
measured in homogenised liver samples. Histograms represent mean 
significance: *p < 0.05; **p < 0.01; ***p < 0.001. GST: glutathione; C
acid reactive substances; MCHL: Musanga cecropioides hydromethanoas viral hepatitis, which account for the profound morbidity
and mortality from liver diseases.18e20 The participation of
hepatic cells in a variety of metabolic activities including
biotransformation and excretion of chemical agents makes
the liver more vulnerable and susceptible to toxicity from
these agents.21 Liver damage is predicated on lipid
peroxidation and cell necrosis.22 This may be an emerging
threat in the Niger Delta environment, where there is a             CAT
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SEM values, with significant changes marked with asterisks. For
AT: catalase; SOD: superoxide dismutase; TBARS: thiobarbituric
lic leaf; CCl4: carbon tetrachloride.
L.L. Nwidu et al. 351massive release of hydrocarbon toxicants from petroleum
exploration and exploitation and natural gas-flaring activ-
ities are ubiquitous. Some of the hydrocarbons released are
likely to be hepatotoxins, as anicteric hepatotoxicity has been
reported as a potential health effect of long-term occupa-
tional exposure in the petroleum refining and distribution
industry in Nigeria.23 The paucity of prognosis of
hepatotoxicity is aggravated by poor treatment or
untreated infective hepatitis, late presentation at hospitals
for treatment, alcoholism, and drug abuse and misuse,
which account for the condition becoming a medical
emergency.24
There is an acute lack of availability of effective drugs that
can stimulate liver function and protect the liver from damage
or help regenerate hepatic cells.25 Herbal drugs have received
considerable attention recently because of their safety,
efficacy, and cost-effectiveness.26 One of the important and
well-documented uses of plant products is their use as hep-
atoprotective agents.27e29 There is a growing need for safe
hepatoprotective agents; hence, several medicinal plants
have been extensively studied for the management of liver
disorders.26,29,30 The literature indicates that
hepatoprotection is possible with plant extracts rich in
antioxidants.31,32 Some plant extracts have already been
reported to possess strong antioxidant activities,33 and their
protective effects are considered, in large part, to be related
to the various constituent antioxidants.34
Anecdotal information from a personal communication
to Nwidu LL indicated that an infusion of MCHL extract is
taken by the Effik people of Akwa Ibom state in Nigeria for
liver regeneration. The effects on haematological indices
revealed that the MCHL extract does not exhibit any pro-
found effects on haematological parameters. Intoxication
with CCl4 significantly (p < 0.05) reduced the WBC count
and the MCHL extract-treated groups exhibited a dose-
dependent increase in leucocytes compared to that in the
positive controls. This finding suggests that the extract
probably contains agent(s) that upregulate the proliferation
of leucocytes. The presence of such agents has been reported
in Viscum album (mistletoe).35,36 This suggests that the
extract may have immune-boosting effects on the animals,
possibly via an increase in vascular permeability. TheMCHL
extract produced no significant dose-dependent increase in
the PLC. However, decreased platelet survival has been re-
ported in liver cirrhosis,37 and an increase in PLC has been
reported to stimulate hepatic regeneration.38 Although
increases in some haematological indices such as RBC
count, PCV, Hb, MCV, MCH, and MCHC were observed,
these were not statistically significant (p > 0.05). Since
plants contain a combination of biomolecules, it can,
therefore, be inferred that some of the active components
in this plant might, in part, act on the bone marrow to
stimulate the production and differentiation of
haematopoietic stem cells.39,40
The liver plays a significant role in detoxification and
metabolic biosynthetic processes such as synthesis of plasma
proteins and gluconeogenesis.41,42 The liver hepatocyte-
regenerative capacity if overwhelmed might result in a
gradual loss of tissue function, leading to liver disorders.43
Acute hepatocellular injury can be induced by various
hepatotoxins, including CCl4 and high-dose acetamino-
phen.31,44e46 CCl4 is biologically inactive and a stablecompound.47 However, it becomes a highly reactive
halogenated aromatic hydrocarbon when it undergoes
biotransformation by cytochrome P450 in the hepatic
endoplasmic reticulum to form a highly reactive and
unstable trichloromethyl radical.48,49 The latter in the
presence of oxygen is metabolised to peroxides and
chloroform, which overwhelm the antioxidant capacity of
the liver, leading to oxidative denaturation of unsaturated
fatty acids of lipid membranes and thereby causing severe
liver damage and membrane leakage.50 This is the
fundamental mechanism of lipid peroxidative degradation
of membranes by CCl4.
51 Damaged liver cells release liver-
specific enzymes into the bloodstream, such as AST, ALT,
and ALP, which are used as biomarkers of liver damage and
indicators for evaluating the effectiveness of therapeutic
agents.52,53
To validate the protective effects of MCHL extract on the
liver enzymes, CCl4-induced hepatotoxicity was investigated.
Significant elevations in the levels of ALT, AST, and ALP,
and serum CBIL and TBIL were observed, reflecting cellular
damage and hepatotoxicity.46,54 Pretreatment with the
MCHL extract before application of CCl4 led to a
significant decrease in the levels of liver biomarker enzymes
AST, ALT, and ALP and serum TBIL and CBIL
(p < 0.001). This finding is in agreement with reports that
serum levels of biomarker enzymes return to near-normal
levels with the healing of the hepatic parenchyma and the
regeneration of hepatocytes.55 This suggests that the MCHL
extract accelerates the healing mechanism of the liver.
Adeneye et al. (2009) evaluated the hepatoprotective ef-
fect of the stem bark of M. ceropioides and observed that
graded doses (125e500 mg/kg) attenuated CCl4-induced or
acetaminophen-induced hepatocellular injury in a dose-
dependent fashion.44 This finding supports our findings, in
that it suggests that the bioactive agents affording
hepatoprotection are similar and present within both the
stem bark and the leaves; however, this will need to be
evaluated in future studies.
Reports indicate that TP and albumin are downregulated
following CCl4 intoxication, suggesting liver damage.
56
Pretreatment with MCHL extracts increased the levels of
serum TP (p < 0.001), and albumin (p < 0.01e0.001).
Stimulation of protein synthesis has been postulated as a
contributing hepatoprotective mechanism, which
accelerates tissue production and regeneration.57
Damage to the liver might impair its ability to excrete
normal amounts of bilirubin or cause obstruction of excre-
tory ducts of the liver.58 Pretreatment with either MCHL
extract or silymarin effectively limited the elevation of the
biliary markers, ALP, and bilirubin levels (CBIL and
TBIL). This suggests that the MCHL extract enhances the
hepatic cell-secretory mechanism and has hepatoprotective
potential.
The percentage hepatoprotection afforded by 70.7 and
141.4 mg/kg MCHL extract/silymarin 100 mg/kg for each
biomarkers is as follows: ALT, 130% and 182%/102%; AST,
128% and 140%/116%; ALP, 127% and 104%/105%; CBIL,
130% and 127%/103%; and TBIL, 124% and 116%/100%,
respectively. This result indicates that the MCHL extract
(70.7 and 141.4 mg/kg) has a more potent hepatoprotective
effect than that of silymarin (100 mg/kg). However, the
highest dose of the MCHL extract (282.8 mg/kg) extract did
Hepatoprotective effect of hydromethanolic leaf extract of Musanga cecropioides352not show significant hepato-protection for these enzyme
biomarkers.
Insults to the liver cytoarchitecture and histomorpho-
logical alterations following acute exposure of the hepato-
cytes to CCl4 are expected. The commonly reported
structural changes in the hepatocytes are sinusoidal dilation,
congestion, inflammation, intense degeneration, vacuolisa-
tion, pyknotic nuclei of necrotic cells with eosinophilic
cytoplasm, nodular cellular damage, and hypertrophic cell
structures.59e61 In this study, gross alteration of the liver
cytoarchitecture was noted in the CCl4-treated group.
Cytoarchitectural irregularities were observed in the
parenchymal structure, with an indistinguishable classical
lobular structure. Treatment with the 141.4 mg/kg MCHL
extract ameliorated the CCl4-induced damage and induced
the generation of mitotic bodies, which is indicative of a
regenerative process62 and suggestive of hepatoprotective
potential. However, the highest dose of the extract was not
effective, and perhaps the extract has pro-oxidant proper-
ties at high doses.
The level of TBARS, the end product of lipid peroxida-
tion, was upregulated in the CCl4-intoxicated group but
pretreatment with the MCHL extract (141.4 mg/kg) signifi-
cantly (p < 0.05) decreased TBARS levels, which was pre-
sumably a reflection of cell membrane repair observed in the
hepatocytes of the extract-treated group as evidenced in the
cytoarchitecture of the liver. In response to oxidative stress,
the cells affected are protected against oxidative insults via
upregulation of the endogenous antioxidant system
including GSH, CAT, and SOD.30 SOD catalyses the
oxidative dismutation of superoxide radicals to molecular
oxygen and hydrogen peroxide, and CAT converts
hydrogen peroxide to molecular oxygen and water.69 The
antioxidant system can easily be overwhelmed by an excess
of lipid peroxides and reactive oxygen species and a
resultant decline in the antioxidant system may render
hepatocytes vulnerable to toxic insults.63 A decrease in the
levels of the antioxidant-system enzymes, CAT, SOD, and
GSH in CCl4 intoxication studies has been reported.
30,41,64
GSH is an endogenous scavenger of free radicals and its
serum level is a sensitive biomarker of antioxidant
status.65,66 The pathophysiological consequences of a
decline in GSH level have been widely investigated; a
decline in the liver GSH level hinges frequently on hepatic
fatty infiltration in different experimental models67e69 A
decrease in the levels of GSH, glutathione (GST), and
glutathione peroxidase (GPx) induces the production of
reactive oxygen species and oxidative stress with
subsequent cascading effects on the functional and
structural integrity of cell and organelle membranes.64 The
reduction of the serum GSH level associated with CCl4
intoxication in the hepatotoxic group may, in part, be
related to free radical generation. Pretreatments with the
MCHL extract mediate an increase in the GSH level,
which may be due to scavenging of free radicals by the
extract. The 43% decrease in GSH levels in CCl4-
intoxicated rats was significantly countered in a dose-
dependent manner by pretreatment with the MCHL
extract, as indicated by the histomorphological data and
suggests tissue injury repair. The MCHL extract stimulated
the recovery of antioxidant potential in the circulation, as
indicated by the marked elevation of GSH level and adecrease in oxidative stress-induced damage in the histopa-
thology data. It has been established that the liver maintains
GSH even under the condition of elevated lipid peroxidation
due to a supportive and compensatory mechanism.66,70
No significant effect was observed on the body weights of
the treated rats throughout the duration of the study. The
effectiveness of the MCHL extract against hepatitis may be
attributable to the presence of phytochemical constituents
such as phenolic acids and flavonoids.9,10 Phenolics are widely
reported to present excellent antioxidant effects against
peroxyl and hydroxyl radicals while flavonoids act as
hydrogen donors and metal chelators.71,72 Currently, further
investigation is ongoing in our laboratories to elucidate the
bioactive agents and the biochemical mechanism responsible
for antioxidant and hepatoprotection by the MCHL extract.
Conclusion
Our study further supports the ethnomedicinal use of the
components of M. cecropioides in treating jaundice and
hepatitis. The stem bark,44 or leaf extract reported herein,
may provide suitable hepatoprotection to liver toxins if
utilised at an appropriate dose. The MCHL extract may be
hepatotoxic at high doses; hence, caution should be
exercised when choosing a dose for the management of
liver injury.
Conflict of interest
The authors disclose receipt of the following financial
assistance for the research, authorship, and or/publication of
this article: Niger Delta University 3-month sabbatical
fellowship and International Visiting Fellowship of the
University of Nottingham, United Kingdom toWGC to host
LLN and EE.
Authors’ contributions
Conception and design, collection and assembly of data,
drafting of the article and final approval of the article,
administrative, technical and logistic support: LLN. Analysis
and interpretation of data, statistical expertise: EE. Histo-
pathological analysis and interpretation of results: YIO.
Critical revision of the article for the important intellectual
content, provision of study materials and obtaining of
funding: WGC. All authors have critically reviewed and
approved the final draft and are responsible for the content
and similarity index of the manuscript.
Acknowledgements
We would like to acknowledge the technical support of
Mr. Obi Cosmas, the technologist attached to the Pharma-
cology Department, and Mr. Obi Sompto for sourcing
experimental animals for this project.
References1. Adeneye AA, Ajagbonna OP, Mojiminiyi FB, Odigie IP,
Ojobor PD, Etarrh RR, Adeneye AK. The hypotensive mech-
anisms for the aqueous stembark extract of Musanga
L.L. Nwidu et al. 353cecropioides in sprague-Dawley rats. J Ethnopharmacol 2006a;
106: 203e207.
2. Kamanyi A, Bopelet M, Tatchum TR. Contractile effect of
some extracts from the leaves of Musanga cecropioides (Cecro-
piaceae) on uterine smooth muscle of the rat. Phytother Res
1992; 6: 165e167.
3. Burkill HM. Musanga cecropioides. Useful plants of West
African, 1; 1985. p. 12.
4. Ayinde BA, Omogbai EKI, Onwukaeme DN. Pharmacognostic
characteristics and hypotensive effects of the stem bark ofMusanga
cecropioides.WAfr J Pharmacol Drug Res 2003; 19: 37e41.
5. Lontsi D, Sondengam BL, Bodo B, Martin MT. Kalaic acid, a
new Ursane e type Saponin from Musanga cecropioides. Planta
Med 1998; 1998(64): 189e191.
6. Dongmo AB, Kamanyi A, Bopelet M. Saponins from the leaves
of Musanga cecropioides constitute a possible source of potent
hypotensive principle. Phytother Res 1996; 10: 23e27.
7. Adeneye AA, Ajagbonna OP, Adeleke TI, Bello SO. Pre-
liminary toxicity and phytochemical studies of the stem bark
aqueous extract of Musanga cecropioides in rats.
J Ethnopharmacol 2006b; 105: 374e379.
8. Adeneye AA, Ajagbonna OP, Ayodele OW. Hypoglycemic and
antidiabetic activities of the stem bark aqueous extracts of
Musanga cecropioides in normal and alloxan-induced diabetic
rats. Fitoterapia 2007; 78: 502e505.
9. Kadiri AB, Ajayi GO. Phyto-anatomical characteristics of the
West African {umbrella tree}Musanga cercropioides M. Smithii
R. Br. (Moraceae). Indian J Sci Technol 2009; 2: 1e5.
10. Buniyamin A, Ayinde D, Onwukaeme N, Eric KO. Isolation
and characterization of two phenolic compounds from the stem
bark of Musanga cecropioides R. Brown (Moraceae). Acta Pol
Pharm Drug Res 2007; 64: 183e185.
11. Trease GE, Evans WC. A textbook of pharmacognosy. London:
Baillie`re Tindall; 2001. p. 600.
12. Lorke D. A new approach to practical acute toxicity testing.
Arch Toxicol 1983; 54: 275e289.
13. Pareek A, Godavarthi A, Issarani R, Nagori BP. Antioxidant
and hepatoprotective activity of Fagonia schweinfurthii (Hadidi)
Hadidi extract in carbon tetrachloride induced hepatotoxicity in
HepG2 cell line and rats. J Ethopharm 2013; 150: 973e981.
14. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys
1958; 82: 70e77.
15. Aebi HE. Catalase. In: Bergmeyer HU, et al., editors. Methods
of enzymatic analysis. 3rd ed. New York: Academic Press; 1983.
pp. 673e684.
16. Kakkar P, Das B, Viswanathan PN. A modified spectropho-
tometric assay of superoxide dismutase. Indian J Biochem Biol
1984; 21: 130e132.
17. Draper HH, Hadley M. Malondiadehyde determination as in-
dex of lipid peroxidation. Meth Enzymol 1990; 186: 421e431.
18. Chitturi S, Farrell G. Drug-induced liver disease. In: Schiff ER,
Sorrell MF, Maddrey WC, editors. Schiff’s diseases of the liver.
9th ed. Philadelphia: Lippincott, Williams & Wilkins; 2002.
pp. 1059e1128.
19. Kaplowitz N. Drug-induced liver injury. Clin Infect Dis 2004;
38: S44eS48.
20. Bhatt S, Kumar H, Sharma M, Saxena KK, Garg G, Singh G.
Evaluation of hepatoprotective activity of Aloe vera in drug
induced hepatitis.World J Pharm Pharmaceut Sci 2015; 4: 935e
944.
21. Wakawa HY, Franklyne EA. Protective effects of Abrus pre-
catorius leaf extract against carbon tetrachloride-induced liver
injury in rats. J Nat Sci Res 2015; 5: 15e19.
22. Obidah W, Garba GK, Fate JZ, Wakawa HY. Protective effect
of Bixa orellana seed oil on carbon tetrachloride induced liver
damage in rats. JOLORN 2010; 11: 19e23.
23. Ezejiofor TIN, Ezejiofor AN, Orisakwe OE, Nwigwe HC,
Osuala FO, Iwuala MO. Anicteric hepatoxicity: a potentialhealth risk of occupational exposures in Nigerian petroleum oil
refining and distribution industry. J Occup Med Toxicol 2014;
9: 3.
24. Adesunkanmi ARK, Akinkuolie AA, Badru OS. A five year
analysis of death in accident and emergency room of a semi-
urban hospital. W Afr J Med 2002; 21: 99e104.
25. Wakawa HY, Musa H. Protective effect of Erythrina senegal-
ensis (DC) leaf extract on CCl4-induced liver damage in rats.
Asian J Bio Sci 2013; 6: 234e238.
26. Brai BIC, Adisa RA, Odetola AA. Hepatoprotective properties
of aqueous leaf extract of Persea americana, mill (lauraceae)
‘avocado’ against CCl4-induced damage in rats. Afr J Tradit,
Complementary Altern Med 2014; 11: 237e244.
27. Ujowundu CO, Nwokedinobi N, Kalu FN, Nwaoguikpe RN,
Okechukwu RI. Ocimum gratissimum in diesel petroleum
induced hepatotoxicity in albino wistar rats. J Appl Pharmaceut
Sci 2011; 1: 56e61.
28. Aluko BT, Oloyede OI, Afolayan AJ. Hepatoprotective activity
of Ocimum americanum L. leaves against paracetamol 
induced liver damage in rats. Am J Life Sci 2013; 1: 37e42.
29. Sangi S, El-feky SA, Ali SS, Ahmedani EI, Tashtoush MH.
Hepatoprotective effects of oleuropein, thymoquinone and fruit
of phoenix dactylifera on CCl4 induced hepatotoxicity in rats.
World J Pharm Pharmaceut Sci 2014; 3: 3475e3486.
30. Aloh GS, Obeagu EI, Odo CE, Kanu SN, Okpara KE,
Udezuluigbo CN, Ugwu GU. Hepatoprotective potentials of
methanol extracts of Gossweilerodendron balsamifarum and lipid
profile of albino rats. Eur J Pharm Med Res 2015; 2: 124e129.
31. El-Sayed MGA, Elkomy A, Samer S, ElBanna AH. Hep-
atoprotective effect of pimpinella anisum and foeniculum vulgare
against carbon tetrachloride induced fibrosis in rats. World J
Pharm Pharmaceut Sci 2015; 4: 78e88.
32. Sur TK, Hazra A, Hazra AK, Bhattacharyya D. Antioxidant
and hepatoprotective properties of Indian Sunderban mangrove
Bruguiera gymnorrhiza L. leave. J Basic Clin Pharm 2016; 7:
75e79.
33. Koa EY, Kim D, Roh SW, Yoonc WJ, Jeon YJ, Ahn G,
Kim KN. Evaluation on antioxidant properties of sixteen plant
species from Jeju Island in Korea. EXCLI J 2015; 14: 133e145.
34. Kuan-Hung L, Yan-Yin Y, Chi-Ming Y, Meng-Yuan H,
Hsiao-Feng L, Kuang-Chuan L, Hwei-Shen L, Pi-Yu C. Anti-
oxidant activity of herbaceous plant extracts protect against
hydrogen peroxide-induced DNA damage in human lympho-
cytes. BMC Res Notes 2013; 6: 490. https://doi.org/10.1186/
1756-0500-6-490.
35. Al-Mamary MA. Antioxidant activity of commonly consumed
vegetables in Yemen. Mal J Nutr 2002; 8: 179e189.
36. Ladokun O, Ojezele M, Arojojoye O. Comparative study on the
effects of aqueous extracts of Viscum album (mistletoe) from
three host plants on hematological parameters in albino rats.
Afr Health Sci 2015; 15: 606e612.
37. Aoki Y, Hirai K, Tanikawa K. Mechanism of thrombocyto-
penia in liver cirrhosis: kinetics of indium-111 tropolone
labelled platelets. Eur J Nucl Med 1993; 20: 123e129.
38. Murata S, Matsuo R, Ikeda O, Ikeda O, Myronovych A,
Watanabe M, Hisakura K, Nakano Y, Hashimoto I,
Ohkohchi N. Platelets promote liver regeneration under con-
ditions of Kupffer cell depletion after hepatectomy in mice.
World J Surg 2008; 32: 1088.
39. Idown AT, Oboh BO, Garuba PNF. Hematological properties
of aqueous extracts of Phyllantus amarus (schum and Thonn.)
and Xylopia aethiopica (dunal) A. Rich in Albino rats. Etheno
Med 2009; 3: 99e103.
40. Onome MI, Omaruyi E, Oyewo EB. Effect of aqeous leaf
extract of Acalypha wilkesiana on hematological parameters in
male wistar Albino rats. Br J Pharmaceut Res 2013; 3: 465e471.
41. Colark E, Ustuner MC, Tekin N, Colark E, Burukoglu D,
Degirmenci I, Gunes HV. The hepatocurative effects of Cynara
Hepatoprotective effect of hydromethanolic leaf extract of Musanga cecropioides354scolymus L. leaf extract on carbon tetrachloride-induced
oxidative stress and hepatic injury in rats. SpringerPlus 2016;
5: 1e9.
42. Chellappan DK, Ganasen S, Btunalai S, Canasamy M,
Krishnappa P, Dua K, Chellian J, Gupta G. The protective
action of the aqueous extract of Auricularia polytricha in
paracetamol-induced hepatotoxicity in rats. Recent Pat Drug
Deliv Formulation 2016; 10: 72e76.
43. Xu L, Gao J, Wang Y, Yu W, Zhao X, Yang X, Zhong Z,
Qian Z. Myrica rubra extracts protect the liver from CCl4-
induced damage. Evid Base Compl Altern Med 2011, 518302.
https://doi.org/10.1093/ecam/nep196.
44. Adeneye AA. Protective activity of stembark aqueous extract of
Musanga cecropiodes in carbon tetrachloride eand acetamino
pheneinduced acute hepatotoxicity in rats. Afr J Tradit,
Compl Altern Med 2009; 2: 131e138.
45. Nithianantham K, Shyamala M, Chen Y, Latha LY, Jothy SL,
Sasidharan S. “Hepatoprotective potential of Clitoria ternatea
leaf extract against paracetamol induced damage in mice.”
Molecules 2011; 16: 10134e10145.
46. Abeer H, Hibah MA, Jihan MB, Amany KI, Seham EA.
“Evaluation of hepatoprotective activity of Adansonia digitata
extract on acetaminophen-induced hepatotoxicity in rats,”. Evid
Base Compl Altern Med 2016; 2016, 4579149. https://doi.org/
10.1155/2016/4579149. 7 pages.
47. Khan RA, Khan MR, Sahreen S. Carbon tetrachloride-induced
hepatotoxicity: protective effect of rutin on p53, CYP2E1 and the
antioxidative status in rat.BMCComplement AlternMed 2012; 12:
178.
48. Shweita SA, Abd El-Gabar M, Bastawy M. Carbon
tetrachloride-induced changes in the activity of phase II drug-
metabolizing enzyme in the liver of male rats: role of antioxi-
dants. Toxicology 2001; 165(2e3): 217e224.
49. Shweita SA, Abd El-Gabar M, BastawyM. Carbon tetrachloride
changes the activity of cytochrome P450 system in the liver of
male rats: role of antioxidants. Toxicology 2001; 169(2): 83e92.
50. Weber LWD, Boll M, Stampfl A. Hepatotoxicity and mecha-
nism of action of haloalkanes: carbon tetrachloride as a toxi-
cological model. Crit Rev Toxicol 2003; 33: 105e136.
51. Srivastava SP, Chen N, Holtzman J. The in vitro NADPH-
dependent inhibition by CCl4 of the ATP-dependent calcium
uptake of hepatic microsomes from male rats. Studies on the
mechanism of the inactivation of the hepatic microsomal calcium
pump by the CCl3. radical. J Biol Chem 1990; 265: 8392e8399.
52. Mir A, Anjum F, Riaz N, Iqbal H, Wahedi HM, Zaman J,
Khattak K, Khan MA, Malik S. Carbon tetrachloride (CCl4)-
induced hepatotoxicity in rats: curative role of Solanum nigrum.
J Med Plants Res 2010; 2010(4): 525e532. https://doi.org/
10.5897/JMPR10.482.
53. Wallace AD, Meyer SA. Hepatotoxicity. In: Smart RC,
Hodgson E, editors. Molecular and biochemical toxicology. 4th
ed. Hoboken: Wiley; 2010. pp. 671e692.
54. Gutie´rrezl RMP, Solı´s RV. Hepatoprotective and inhibition of
oxidative stress in liver of Prostechea michuacana. Record Nat
Prod 2009; 3: 46e51.
55. Jain R, Nandakumar K, Srivastava1 V, Vaidya SK, Patet S,
Kumar P. Hepatoprotective activity of ethanolic and aqueous
extract of Terminalia belerica in rats. Pharmacologyonline 2008;
2: 411e427.
56. Navarro VJ, Senior JR. Drug-related hepatotoxicity. N Engl J
Med 2006; 354: 731e739.
57. Tadeusz J, Teresa J, Krzysztof N. The role of polyprenol in
modulation of physical properties of model membranes. Curr
Top Biophys 2001; 25: 33e38.
58. Gaw A, Cowan RA, O’Reilly D St. J, Stewart MJ, Shepherd J.
Clinical biochemistry an illustrated colour text. 2nd ed. Edin-
burgh: Harcourt Brace; 1999. p. 165.59. Hsiao G, Lin YH, Lin CH, Chou DS, Lin WC, Sheu JR. The
protective effects of PMC against chronic carbon tetrachloride-
induced hepatotoxicity in vivo. Biol Pharm Bull 2001; 24: 1271e
1276.
60. Mehmetc¸ik G, O¨zdemirler G, Kocak-Toke RN, C¸evikbas U,
Uysal M. Effect of pretreatment with artichoke extract on
carbon tetrachloride-induced liver injury and oxidative stress.
Exp Toxicol Pathol 2008; 60: 475e480.
61. Cuciureanu M, Caruntu I-D, Paduraru O, Stoica B, Jerca L,
Crauciuc E, Nechifor M. The protective effect of montelukast
sodium on carbon tetrachloride induced hepatopathy in rat.
Prostag Other Lipid Mediat 2009; 88: 82e88.
62. Battochio AP, Coelho KL, Sartoli MS, Coelho CA. Hep-
atoprotective effect of water soluble extract of Coleus barbatus
on cholestasis on young rats. Acta Cir Bras 2008; 23: 220e
229.
63. Ajiboye TO. In vivo antioxidant potentials of Piliostigma
thonningii(Schum) leaves: studies on hepatic marker enzyme,
antioxidant system, drug detoxifying enzyme and lipid peroxi-
dation. Hum Exp Toxicol 2010; 30: 55e62. https://doi.org/
10.1177/0960327110366785.
64. Adebayo AH, Abolaji AO, Kela R, Oluremi SO, Owolabi OO,
Ogungbe OA. Hepatoprotective activity of Chrysophyllum
albidum against carbon tetrachloride induced hepatic damage in
rats. Can J Pure Appl Sci 2011; 2: 1597e1602.
65. Spolarics Z, Meyenhofer M. Augmented resistance to oxidative
stress in fatty rat livers induced by a short-term sucrose-rich
diet. Biochim Biophys Acta 2000; 1487: 190e200.
66. Piemonte F, PasStose A, Tozzi G, Taqliacozzi D,
Santorelli FM, Carrozzo R, Cassali C, Damiano M, Fderici G,
Bertini E. Glutathione in blood of patients with Freidereich’s
ataxia. Eur J Clin Invest 2001; 31: 1007e1011.
67. Al-Asmari AK, Al-Elaiwi AM, Athar MT, Tariq M, Al-Eid A,
Al-Asmary SM. Review of hepatoprotective plants used in
saudi traditional medicine. Evid Base Compl Altern Med 2014;
1: 22.
68. El-Hadary AE, Ramadan MF. Potential protective effect of
cold-pressed coriandrum sativum oil against carbon
tetrachloride-induced hepatotoxicity in rats. J Food Biochem
2015; 40: 190e200.
69. Awogbindin IO, Tade OG, Metibemu SD, Olorunsogo OO,
Farombi EO. Assessment of flavonoid content, free radical
scavenging and hepatoprotective activities of Ocimum gratissi-
mum and Spondias mombin in rats treated with dimethylnitro-
samine. Arch Bas App Med 2014; 2: 45e54.
70. Valencia E, Marin A, Hardy G. Glutathione nutritional and
pharmacological viewpoints: Part II. Nutrition 2001; 17: 485e
486.
71. Ayaz M, Junaid M, Subhan F, Ullah F, Sadiq A, Ahmad S,
Imran M, Kamal Z, Hussain S, Shal SM. Heavy metals anal-
ysis, phytochemical, phytotoxic and anthelmintic investigations
of crude methanolic extract, subsequent fractions and crude
saponins from Polygonum hydropiper L. BMC Complement
Altern Med 2014; 14: 465.
72. KamalZ,UllahF,AyazM,SadiqA,AhmadS,ZebA,HussainA,
Imran M. Anticholinesterase and antioxidant investigations of
crude extracts, subsequent fractions, saponins and flavonoids of
Atriplex laciniata L.: potential effectiveness in Alzheimer’s and
other neurological disorders. Biol Res 2015; 48: 21.How to cite this article: Nwidu LL, Oboma YI, Elmorsy E,
Carter WG. Hepatoprotective effect of hydromethanolic
leaf extract of Musanga cecropioides (Urticaceae) on
carbon tetrachloride-induced liver injury and oxidative
stress. J Taibah Univ Med Sc 2018;13(4):344e354.
